Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrocortisone is a synthetic or pharmaceutical form of the naturally occurring hormone cortisol, classified as a corticosteroid. It acts primarily by binding to glucocorticoid receptors, exerting anti-inflammatory and immunosuppressive effects. Hydrocortisone is used to treat adrenal insufficiency (such as Addison's disease), severe allergic reactions, various inflammatory and autoimmune conditions (including arthritis, lupus, asthma, dermatitis), certain cancers, and other disorders requiring suppression of inflammation or immune response. It can be administered orally, topically, intravenously/intramuscularly, rectally (suppositories), or via buccal tablets for mouth ulcers. Its mechanism involves reducing swelling and redness by modulating gene expression related to immune function and inflammation[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrocortisone.